Showing results (81-90 of 348) with videos related to

Sort By:
Pageof 35
Oncotarget|July 3, 2018
PKM2 under hypoxic environment causes resistance to mTOR inhibitor in human castration resistant prostate cancerYota Yasumizu, Hiroshi Hongo, Takeo Kosaka, et al.
Clinical Imaging|August 21, 2018
Performance of diffusion-weighted MRI post-CT urography for the diagnosis of upper tract urothelial carcinoma: Comparison with selective urine cytology samplingHirotaka Akita, Eiji Kikuchi, Nozomi Hayakawa, et al.
Annals of Surgical Oncology|September 11, 2016
Urinary pH Levels are Strongly Associated with Bladder Recurrence After Nephroureterectomy in Upper Tract Urothelial Carcinoma Patients with a Smoking HistoryHiroki Ide, Eiji Kikuchi, Masayuki Hagiwara, et al.
Human Gene Therapy|May 11, 2011
Intravesical interleukin-15 gene therapy in an orthotopic bladder cancer modelKazuhiro Matsumoto, Eiji Kikuchi, Minoru Horinaga, et al.
Cancer Medicine|October 25, 2013
Therapeutic enhancement of S-1 with CPT-11 through down-regulation of thymidylate synthase in bladder cancerHiroki Ide, Eiji Kikuchi, Masanori Hasegawa, et al.
The Journal of Urology|April 12, 2005
Prostate specific antigen adjusted for transition zone epithelial volume: the powerful predictor for the detection of prostate cancer on repeat biopsyTakashi Ohigashi, Kent Kanao, Eiji Kikuchi, et al.
Japanese Journal of Clinical Oncology|May 21, 2008
The predictors of local recurrence after radical cystectomy in patients with invasive bladder cancerHiroki Ide, Eiji Kikuchi, Akira Miyajima, et al.
Urologia Internationalis|March 26, 2008
Simple stratification of survival using bone scan and serum C-reactive protein in prostate cancer patients with metastasesJun Nakashima, Eiji Kikuchi, Akira Miyajima, et al.
The Journal of Urology|November 11, 2005
Lymphovascular invasion independently predicts increased disease specific survival in patients with transitional cell carcinoma of the upper urinary tractEiji Kikuchi, Yutaka Horiguchi, Jun Nakashima, et al.
International Journal of Clinical Oncology|December 19, 2008
Gemcitabine and paclitaxel chemotherapy for advanced urothelial carcinoma in patients who have received prior cisplatin-based chemotherapyKunimitsu Kanai, Eiji Kikuchi, Takashi Ohigashi, et al.
Pageof 35